Abevmy is approved for treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3vk6cpH
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Biocon Biologics, Viatris receive approval for cancer drug
0 comments:
Post a Comment